CompletedNot Applicable

Evaluation of the Effect of Novel Recruitment Maneuver Therapy for Postoperative Pulmonary Atelectasis

China77 participantsStarted 2023-09-10

Plain-language summary

1. Oxygenation index and bedside ultrasound would be used to evaluate the therapeutic effect of novel recruitment maneuver therapy in the patients with pulmonary atelectasis after cardiac surgery. 2. To establish a new therapy strategy for pulmonary atelectasis after cardiac surgery and to evaluate its effectiveness and safety for the cardiac patients complicated with postoperative pulmonary atelectasis.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Underwent cardiac surgery with CPB * Patients with lung ultrasound evidence of atelectasis after surgery * Agree to participate in this study by themselves or their family member. Exclusion Criteria: * Vasoactive-inotropic score (VIS)\>20 * Patients who were not suitable for using abdominal CPR compression-decompression instrument: bleeding from abdominal organs, abdominal aortic aneurysm, large abdominal tumor, intra-abdominal hypertension, etc * Hemothorax or large pleural effusion confirmed by ultrasonography/X-ray * Pneumothorax or air leak confirmed by ultrasonography/X-ray * Considered by other researchers to be unsuitable for participation in this study

What they're measuring

Lung ultrasound score (LUSS)

Timeframe: 5 min before treatment and 5 min after treatment

Trial details

NCT IDNCT06049173

SponsorJilai Xiao

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-20

View on ClinicalTrials.gov More Postoperative Pulmonary Atelectasis trials